Chemical Proteomic Assay for Optimizing Drug Binding to Target Proteins

• US 20100304998A1
• Filed: 06/02/2010
• Published: 12/02/2010
• Est. Priority Date: 06/02/2009
• Status: Abandoned Application

• Current Assignee: Marquette University
• Original Assignee: Marquette University
• Inventors: Sem, Daniel S.
• Application Number:
  US12/792,398
• Publication Number:
  US 20100304998A1
• Time in Patent Office: Days
• US Class Current: 506/9
• CPC Class Codes: G01N 33/6842 Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
• CPC Class Codes: G01N 33/6848 Methods of protein analysis involving mass spectrometry

Abstract

Disclosed herein are methods related to drug development. The methods typically include steps whereby an existing drug is modified to obtain a derivative form or whereby an analog of an existing drug is identified in order to obtain a new therapeutic agent that preferably has a higher efficacy and fewer side effects than the existing drug.

Claims

1. A method comprising:

(a) passing a biological sample comprising a target protein and optionally a non-target protein over a column, the column comprising an affinity resin for the target protein, the affinity resin comprising a resin conjugated or covalently attached to a first chemical compound that binds to the target protein;

(b) washing the column and removing proteins that are not bound to the affinity resin;

(c) eluting proteins from the column that are bound to the affinity resin by passing a solution comprising a second chemical compound over the column; and

(d) identifying proteins in the eluate, thereby obtaining a proteomic profile for the second chemical compound.

2. The method of claim 1 further comprising:

(e) comparing the proteomic profile of the second chemical compound to a proteomic profile of the first chemical compound obtained by eluting proteins from the column that are bound to the affinity resin by passing a solution comprising the first chemical compound over the column.

3. The method of claim 1, wherein the second chemical compound is a derivative or analog of the first chemical compound and binds to the target protein.

4. The method of claim 1, wherein the first chemical compound and the second chemical compound are selected from Tables 6-9.

5. The method of claim 1, wherein identifying the proteins in the eluates comprises performing sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE).

6. The method of claim 5, further comprising measuring intensities of bands in the gel by electronically scanning the gels and performing densitometry analysis.

7. The method of claim 1, wherein proteins in the eluate are identified by performing tandem mass spectrometry (MS) analysis.

8. The method claim 5, further comprising excising separate bands from the gels and performing tandem MS analysis each excised band.

9. The method of claim 1, wherein the first chemical compound is DMP543 or an analog or derivative thereof that inhibits KCNQ (Kv7) channel activity.

10. The method of claim 9, wherein DMP543 is conjugated or covalently attached to the resin as follows:

11. The method of claim 1, wherein the first chemical compound is XE991 or an analog or derivative thereof that inhibits KCNQ (Kv7) channel activity.

12. The method of claim 11, wherein XE991 is conjugated or covalently attached to the resin as follows:

13. The method of claim 1, wherein the first chemical compound is linopirdine or an analog or derivative thereof that inhibits KCNQ (Kv7) channel activity.

14. The method of claim 13, wherein linopirdine is conjugated or covalently attached to the resin as follows:

15. The method of claim 1, wherein the first chemical compound is CRAA.

16. The method of claim 1, wherein the first chemical compound is glitazone.

17. The method of claim 1, wherein the biological sample is selected from a neurological tissue sample, a liver tissue sample, a heart tissue sample, and a kidney tissue sample.

18. A method comprising:

(a) passing a biological sample comprising proteins over columns comprising a chemical-resin library, wherein each column comprises a separate member of the chemical-resin library and the chemical-resin library comprises a separate chemical compound conjugated to a resin;

(b) washing each column to remove any non-bound proteins;

(c) eluting any bound proteins from each column; and

(d) identifying proteins in the eluates, thereby generating a proteomic profile for each column, and optionally comparing the proteomic profiles for two or more columns.

19. A method comprising:

(a) passing a biological sample comprising a target protein and a non-target protein over a first column, the first column comprising an affinity resin for the target protein, the affinity resin comprising a resin conjugated or covalently attached to a first chemical compound that binds to the target protein;

(b) washing the first column and removing proteins that are not bound to the affinity resin;

(c) eluting proteins from the first column that are bound to the affinity resin;

(d) identifying proteins in the eluate including the target protein and optionally the non-target protein;

(e) passing the biological sample comprising the target protein and the non-target protein over a second column, the second column comprising an affinity resin for the target protein, the affinity resin comprising a resin conjugated or covalently attached to a second chemical compound that binds to the target protein;

(f) washing the second column and removing proteins that are not bound to the affinity resin;

(g) eluting proteins from the second column that are bound to the affinity resin; and

(h) identifying proteins in the eluate including the target protein and optionally the non-target protein.

20. The method of claim 19, wherein the second chemical compound is a derivative or analog of the first chemical compound that binds the target protein with an affinity no less than the first chemical compound and that binds the non-target protein with an affinity less than the first chemical compound.